Australia markets closed

Comera Life Sciences Holdings, Inc. (CMRA)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.0595+0.0215 (+56.58%)
At close: 01:43PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
Total revenue
1,000
633.102
319.832
442.919
Cost of revenue
264.88
210.39
161.008
104.407
Gross profit
735.52
422.712
158.824
338.512
Operating expenses
Research development
1,435
1,740
1,753
1,262
Selling general and administrative
8,448
10,653
3,942
1,204
Total operating expenses
9,882
12,393
5,694
2,466
Operating income or loss
-9,147
-11,970
-5,536
-2,128
Interest expense
25.177
20.391
0
-
Total other income/expenses net
162.783
-6,014
83.85
2.033
Income before tax
-9,009
-18,004
-5,452
-2,125
Income from continuing operations
-9,009
-18,004
-5,452
-2,125
Net income
-9,009
-18,004
-5,452
-2,125
Net income available to common shareholders
-9,353
-18,378
-5,452
-2,125
Basic EPS
-0.22
-1.76
-0.29
-0.11
Diluted EPS
-0.22
-1.76
-0.29
-0.11
Basic average shares
19,568
10,453
19,087
19,087
Diluted average shares
19,568
10,453
19,087
19,087